/**
 * Content source for /compare/pecanrev-vs-covidence — 113 W1-A.
 *
 * Policy (see compare-index.js): only publicly documented competitor
 * capabilities, neutral phrasing, no pricing, no ratings, no invented feature
 * matrix, dated verification line, link to the vendor's own site. PecanRev
 * claims restate the verified feature-page claims only.
 */

export default `---
h1: PecanRev vs Covidence
title: PecanRev vs Covidence: Systematic Review Software Compared
description: An honest comparison of two systematic review platforms: what Covidence is known for, how PecanRev differs, and which one fits the review you are running.
slug: compare/pecanrev-vs-covidence
published: 2026-08-10
updated: 2026-08-10
author: The PecanRev team
---

Covidence is a well-established web platform for the screening and data-extraction stages of a systematic review, widely used in Cochrane review production and documented as exporting to RevMan and CSV for analysis. PecanRev covers the same stages and continues through statistical synthesis, PRISMA reporting and the manuscript inside the same project. If your team already has a settled analysis and writing pipeline, Covidence slots into it; if you want the pooled estimate and the draft to stay tied to the screening ledger they came from, that is the difference PecanRev is built around.

## What is Covidence known for?

According to [Covidence's own site](https://www.covidence.org), the platform covers reference import with automatic duplicate detection, title and abstract screening designed around two independent reviewers with built-in conflict resolution, full-text review with recorded exclusion reasons, template-based data extraction with a consensus step, risk-of-bias assessment, a PRISMA flow diagram generated from the screening activity, and export to RevMan and CSV.

Three things about it are worth naming plainly, because they are genuine strengths:

- **The dual-reviewer model is the default, not a setting.** Screening in Covidence is shaped around two people disagreeing and a third resolving it, which is the model most guidelines assume.
- **It is deeply embedded in Cochrane review production**, and the RevMan export path is the reason many Cochrane author teams use it.
- **It is mature and widely taught.** Many institutional libraries run Covidence training, so a new team member is likely to have seen it before.

## Where does PecanRev differ?

**The workflow does not stop at extraction.** PecanRev computes the meta-analysis in the same project as the extracted data: fixed-effect and random-effects estimates for every analysis, eight tau-squared estimators, Hartung-Knapp-Sidik-Jonkman intervals, heterogeneity statistics with prediction intervals, forest and funnel plots, Egger's test and trim-and-fill, subgroup analysis, meta-regression, leave-one-out and influence diagnostics, and a frequentist [network meta-analysis](/features/network-meta-analysis) engine. There is no export step between extraction and pooling.

**The manuscript is part of the project.** The draft stores references to project facts rather than transcribed numbers, so study counts, PRISMA numbers and pooled estimates update in the text when the project changes, and the Abstract cannot disagree with the Results. Methods text is generated from execution records — only databases that were actually searched are named. See the [manuscript editor](/features/manuscript).

**PRISMA is record-level, not count-level.** Every record carries where it came from and what happened to it, and the [flow diagram](/features/prisma-flow-diagram) is derived from that ledger. A database that returned zero results is reported as zero rather than dropped.

**Case reports and case series are modelled directly.** In [case series mode](/features/case-series) a case is a study row tagged with its publication, so several patients can be extracted from one paper while the PRISMA counts keep reporting publications.

**Extraction records provenance at the value level.** Click a number in the PDF and it is captured with its page, region and excerpt; derived values name the conversion, the formula and the literature reference that produced them, and originals are never overwritten. See [data extraction](/features/data-extraction).

## When is Covidence the better fit?

- You are producing a Cochrane review and want the RevMan path that Cochrane's own workflow is built around.
- Your institution already provides Covidence and your team is trained on it.
- Your analysis and writing already happen elsewhere and you want a screening and extraction tool that stays in its lane.

## When is PecanRev the better fit?

- You want one audit trail from search to manuscript, with no export boundary between extraction and analysis.
- Your review pools proportions or single-arm data, or runs a network meta-analysis, and you would rather not move the dataset to another package.
- Your evidence base is case reports and case series, and you need many patients under one publication without inflating the flow diagram.
- You care that the write-up cannot silently disagree with the data behind it.

## What both platforms take seriously

Both are built around the same non-negotiables: two independent reviewers, recorded exclusion reasons at full text, a consensus step for extraction disagreements, and a PRISMA flow diagram derived from what the team actually did rather than typed in afterwards. In their default configurations neither tool decides whether a study is included. That is worth saying, because a comparison that implies otherwise would be misleading about both products. PecanRev ships one off-by-default exception — a criteria screener an administrator can put into governed auto-apply, which writes under a system reviewer identity and never over a person's decision — and it is described on [AI in systematic reviews](/ai-systematic-review).

## How this comparison was written

We describe only capabilities that Covidence documents publicly on its own site, we do not publish pricing or ratings for a product we do not build, and we do not speculate about features we cannot verify. Where a boundary is named, it is a documented scope decision — for example that analysis happens in RevMan — not a judgement about quality.

Information verified as of August 2026. Products change; confirm anything decision-critical against [covidence.org](https://www.covidence.org) before you choose.

## References

- Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at [covidence.org](https://www.covidence.org).
- [PecanRev feature documentation](/features) — every PecanRev claim on this page is described in more detail on the relevant feature page.
`;
